Pemirolast use while Breastfeeding
Drugs containing Pemirolast: Alamast
Pemirolast Levels and Effects while Breastfeeding
Summary of Use during Lactation
Although no published data exist on the use of pemirolast during lactation, maternal milk levels are likely to be very low after the use eye drops.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Possible Effects on Lactation
Relevant published information was not found as of the revision date.
References
Pemirolast Identification
Substance Name
CAS Registry Number
69372-19-6
Drug Class
- Anti-Allergic Agents
- Histamine Antagonists
Administrative Information
LactMed Record Number
781
Information from the National Library of Medicine's LactMed Database.
Last Revision Date
2009-09-29
Disclaimer
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
See Also...
- Pemirolast ophthalmic use during Pregnancy
- Pemirolast Consumer Information
- Breastfeeding Support Group
- Safe Medications during Breastfeeding
- Medicine use while Breastfeeding
- Medicine use during Pregnancy
Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.
